U.S. Advanced Wound Care Market Size, Share & COVID-19 Impact Analysis, By Product Type (Advanced Wound Dressings {Alginate Dressings, Hydrogel Dressings, Film Dressings, Hydrocolloid Dressings, Antimicrobial Dressings, Foam Dressings, Others}, Wound Care Devices {Negative Pressure Wound Therapy, Hyperbaric Oxygen Therapy, Others}, and Active Wound Care {Biological Skin Equivalents, Growth Factors, Biological Dressings, and Others}), By Indication (Diabetic Foot Ulcers, Pressure Ulcers, and Others), By End User (Hospitals, Clinics, Homecare Settings, and Others), and Forecast, 2023-2030

The U.S. advanced wound care market size was USD 4.22 billion in 2022. The market is projected to grow from USD 4.45 billion in 2023 to USD 6.54 billion by 2030, exhibiting a CAGR of 5.6% during the forecast period.

Advanced wound care products are mainly used when standard products fail to heal the wounds properly. Wounds such as chronic ulcers, which are unresponsive to initial wound care, are generally treated with advanced wound care therapies. Collagen products, biological skin equivalents, and Negative Pressure Wound Therapy (NPWT), among others are considered under these therapies. The rising prevalence of geriatric population in the country is one of the factors leading to an increased demand for these products. Aging population is leading to rise in age-related chronic conditions including disability, diabetes, vascular diseases, and others. This is presenting a large patient population at higher risk of developing chronic wounds.

• According to the U.S. Census Bureau, an estimated 16.9% of the U.S. population (more than 56.0 million) are aged 65 years and above, which is estimated to reach more than 73.1 million by the end of the year 2030. It has been demonstrated that the risk of developing chronic wounds and the ability to heal wounds decreases with increased age.

Additionally, the constant efforts by the key players to launch new advanced products for wound treatment and rising initiatives by the government to raise awareness regarding proper wound management are some factors leading to an increase in the uptake of advanced wound care products in the upcoming years.

COVID-19 IMPACT

Canceled Visits During the Pandemic Hampered the Market Growth 

During the COVID-19 pandemic, wound management was exempted from the list of essential procedures by the country, due to which the market in the country was negatively impacted. The market was also slowed down due to a decline in the number of patient visits to wound care clinics, the implementation of nationwide lockdown, and disruption in the demand and supply chain, among others.

• According to an article published by HMP Global in 2021, about 60% of the hospital-based outpatient department observed a reduction in patient visits. Also, more than 20% of the clinics were shut during the pandemic.

Additionally, various market players in the country observed a significant decline in their revenue generation during the pandemic.

• For instance, Convatec Group PLc observed a decline of 4% in its revenue in 2020 when compared to 2019.

However, the market witnessed normal growth owing to the adoption of telemedicine by healthcare professionals to treat the patients suffering from various wounds and the resumption of surgeries across the globe.

LATEST TRENDS

Rising Launch of Active Therapies for Wound Management

This market is witnessing a shifting trend toward adopting bioactive wound care products among the population owing to various benefits associated with these products. Bioactive wound care products when compared to conventional products exhibit faster wound healing process, and reduced risk of infection, among others. Also, to cater to the rising demand for these products, companies have shifted their focus in developing and launching various bioactive wound care therapies.

Furthermore, governments provide a conducive environment for the approvals and launch of advanced products to manage chronic wounds among patients. This is expected to bolster the U.S. advanced wound care market growth in the forthcoming years.

• For instance, in March 2023, ConvaTec Group PLC received the U.S. FDA clearance for its placental extracellular matrix, InnovaBurn, to manage second-degree burns and complex surgical wounds.

DRIVING FACTORS

Rising Prevalence of Acute and Chronic Wounds to Expand the Market Share

The rising prevalence of chronic wounds, such as diabetic foot ulcers, venous leg ulcers, and pressure ulcers, and increasing incidence of acute wounds owing to injuries and surgical procedures in the country are prominent factors raising the demand for these products.

• For instance, according to data published by the American Burn Association Registry, an estimated 91,875 people were treated with burn injuries, of which 32% suffered from scalds.

Additionally, to meet the rising demand among patients due to increasing prevalence, companies and the country’s government are continuously trying to launch technologically advanced products in the market, which is anticipated to raise the uptake of these products in the forthcoming years.

• For instance, in June 2021, the U.S. FDA cleared Mölnlycke Health Care AB’s Avance Solo NPWT System intended to remove low to moderate exudate from acute and chronic wounds.

RESTRAINING FACTORS

Increase in Product Recalls to Hamper the Market Growth

Despite the fact that companies have increased their capacity for manufacturing advanced products to cater to the rising demand, frequent product recalls of many products limited the market growth. Manufacturing defects in the product, hampered product quality, and others have hindered the brand presence of these companies and their products, thus limiting the adoption of these products.

• For instance, in November 2022, the ConvaTec Group PLC initiated a voluntary product recall for its AQUACEL Foam Ag Adhesive due to the contamination observed in the form of brown spots in several dressings.


• Moreover, in June 2020, Cardinal Health initiated the class 2 recall for its NPWT Canister with Gel 300cc due to manufacturing default in the device.

SEGMENTATION

By Product Type Analysis

Advanced Wound Dressings Segment to Dominate the Market Owing to the Launch of Technologically Advanced Products

On the basis of product type, the market is segmented into advanced wound dressings, wound care devices, and active wound care. The advanced wound dressings segment held a dominating market share in 2022 and is expected to continue its dominance in the upcoming years. The wide availability of advanced wound dressings, cost-effectiveness of the products, and the approval of new products are a few factors promoting the U.S. advanced wound care market growth.

• For instance, in June 2022, Collagen Matrix, a U.S. based regenerative medicine company received the FDA approval for its new fibrillary collagen wound dressing to treat chronic wounds such as diabetic ulcers, venous stasis ulcers, and acute wounds such as trauma and surgical wounds.

On the other hand, the active wound care segment is expected to observe lucrative growth in the forthcoming years owing to benefits offered by the products to promote regeneration and support the re-epithelization process.

• In October 2021, Kerecis received marketing authorization from the U.S. FDA for its product Omega3 SurgiBind, a fish-skin graft that accelerates the faster wound closure.

Moreover, the wound care devices segment is projected to grow at a significant CAGR during the forecast period. The rise in traumatic wounds, the number of surgeries, and the launch of technologically advanced wound care devices contribute to the market growth.

By Indication Analysis

Diabetic Foot Ulcers Segment to Dominate Owing to Rising Diabetes Prevalence among the U.S. Population

On the basis of indication, the market is segmented into diabetic foot ulcers, pressure ulcers, surgical wounds, and others. The growing prevalence of diabetic ulcer among the population is leading to a rising demand for wound care products. Additionally, strong reimbursement scenario in the country for wound treatment is contributing to the increased adoption of these products among the population.

• According to the Centers for Disease Control and Prevention 2022 data, an estimated 11.3% of the country’s population (37.3 million) was affected with diabetes in 2019. Thus, the increased diabetic population will contribute to the market growth.

On the other hand, pressure ulcers and surgical wounds segments are anticipated to exhibit a considerable growth during the forecast period. The increasing prevalence of geriatric population and rising number of hospital inpatient admissions with increasing length of stay, is likely to drive the adoption for wound care products.

• According to an article published by the American Medical Association in 2021, about 13.0 million surgeries were performed in the country from January 2019 to January 2021.

By End User Analysis

Rising Number of Surgeries to Propel Hospitals Segment Growth

Based on end user segment, the market is segmented into hospitals, clinics, homecare settings, and others.

The hospitals segment accounted for the largest market share in the end user segment owing to the rising number of surgeries, increase in hospital admission with regards to wound management, reimbursement provided by the hospitals, and hospitals adopting advanced wound care products to manage and heal wounds.

• For instance, in January 2021, University Hospitals Richmond Medical Center became the first healthcare setting in Ohio, U.S. to use the dermaPace system developed by Sanuwave for treating wounds. The device delivers acoustic shock waves to heal wounds through the formation of new blood vessels. Such technological advancements in products are anticipated to raise their adoption in the country.

Homecare settings segment is anticipated to grow at a higher CAGR during the forecast period. The increasing shift of patients toward home healthcare due to its cost-effectiveness when compared to the long hospital stays required for wound treatment is one of the predominant factors contributing to the segment growth. Furthermore, the launch of products to be used in homecare settings is expected to support the market growth.

• In December 2021, the U.S. FDA cleared Smith & Nephew’s PICO 7 Single Use Negative Pressure Wound Therapy (NPWT) System intended to remove exudate from various wound types. The system can be used in hospitals and home care settings.

KEY INDUSTRY PLAYERS

Smith & Nephew, Convatec Group PLC, and 3M to Lead the Market with Strong Product Offerings

Smith & Nephew, 3M, and Convatec Group PLC are the players currently leading the U.S. advanced wound care market share. The presence of a strong product portfolio and remarkable distribution network in the country are major factors strengthening their industry presence. Moreover, rising initiatives by these companies to strengthen their market position by launching new products, collaboration, and partnerships with various healthcare organizations and others also promote their revenue growth in the forthcoming years.

• For instance, in January 2023, Convatec Group PLC launched ConvaFoam, an advanced wound dressing in the U.S. Through this launch, the company aims to cater to the growing patient demand and strengthen its market position.

Other players such as MiMedx, Tissue Regenix, Organogenesis, Inc. are also focused toward launching novel products, which is expected to increase their growth in the upcoming years.

• For instance, in January 2023, MiMedx entered into an exclusive distribution agreement with Gunze Medical, a leading distributor of wound care products, to launch Epifix in Japan.

LIST OF KEY COMPANIES PROFILED:

• 3M (U.S.)


• Smith & Nephew (U.K.)


• MiMedx (U.S.)


• Coloplast Corp (Denmark)


• ConvaTec Group PLC (U.K.)


• Tissue Regenix (U.S.)


• Derma Sciences, Inc.(U.S.)


• Organogenesis, Inc. (U.S.)


• Integra LifeSciences (U.S.)


• Mölnlycke Health Care AB (Sweden)

KEY INDUSTRY DEVELOPMENTS

• August 2022: Organogenesis Inc. received the U.S. FDA clearance for PuraPly MZ, brand extension of the PuraPly product. The product provides an option to surgeons for complex surgical wounds.


• March 2022: ConvaTec Group PLC acquired Triad Life Sciences, focused on developing wound biologics, to address the unmet need in the wound caused due to surgeries and strengthen its advanced wound care product portfolio.


• February 2022: Winner Medical received the U.S. 510k approval for its silver alginate dressing. Through this approval, the company aimed to expand its market in the country.


• December 2021: Clear Choice Therapeutics, Inc. received the U.S. FDA approval for Theia NPWT Foam Wound Dressing Kit to be used in combination with CCT Mini or CCT1 NPWT Wound Drainage Pumps.

REPORT COVERAGE

The market research report provides a detailed analysis of the market and focuses on key aspects such as leading companies, competitive landscape, products, applications, and end users. Besides this, it offers insights into the market trends and highlights key industry developments. In addition to the factors mentioned above, the report encompasses several factors that have contributed to the growth of the market in recent years.

Report Scope & Segmentation